文献速递类风湿关节炎

类风湿关节炎中炎症与心力衰竭及其亚型的关联

Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-12-12

本研究基于电子健康记录构建的类风湿关节炎队列,纳入9,087例患者,分析基线炎症与随访10年内新发心力衰竭及其亚型的关联。结果显示,基线炎症升高与心力衰竭风险增加相关(5年HR 1.66,10年HR 1.46),该关联由射血分数保留的心力衰竭驱动,而与射血分数降低的心力衰竭无关。

要点

  • 基线炎症升高与类风湿关节炎患者5年和10年新发心力衰竭风险增加相关。
  • 炎症与射血分数保留的心力衰竭风险增加相关,与射血分数降低的心力衰竭无关。
  • 提示类风湿关节炎确诊早期可能是预防射血分数保留的心力衰竭的机会窗口。

核心结论

  • 类风湿关节炎诊断早期炎症升高与心力衰竭风险增加相关,该关联由射血分数保留的心力衰竭驱动而非射血分数降低的心力衰竭。

研究设计与样本

  • 基于电子健康记录的类风湿关节炎队列研究,纳入9,087例患者,随访自类风湿关节炎发病日期至新发心力衰竭、死亡、末次记录或10年。
  • 采用验证方法识别心力衰竭并通过射血分数分类为射血分数降低的心力衰竭和射血分数保留的心力衰竭。
  • 基线炎症采用红细胞沉降率或C反应蛋白评估,使用Cox比例风险模型检验关联。

主要发现

  • 9,087例类风湿关节炎患者中8.2%在10年随访期间发生心力衰竭。
  • 炎症升高与5年随访心力衰竭风险增加相关(HR 1.66,95%CI 1.12-2.46),10年随访亦相关(HR 1.46,95%CI 1.13-1.90)。
  • 炎症升高与5年射血分数保留的心力衰竭风险增加相关(HR 1.72,95%CI 1.09-2.70),10年亦相关(HR 1.45,95%CI 1.07-1.94)。
  • 射血分数降低的心力衰竭在5年和10年随访中均与炎症无关联。

临床怎么用

  • 对类风湿关节炎确诊时炎症升高的患者,应关注射血分数保留的心力衰竭的预防。
  • 类风湿关节炎确诊早期可能是预防射血分数保留的心力衰竭的机会窗口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In rheumatoid arthritis (RA), there are limited data on risk factors for the clinical heart failure (HF) subtypes of HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). This study examined the association between inflammation and incident HF subtypes in RA. Because inflammation changes over time with disease activity, we hypothesized that the effect of inflammation may be stronger at the 5-year follow-up than at the standard 10-year follow-up from general population studies of cardiovascular risk. METHODS: We studied an electronic health record (EHR)-based RA cohort with data pre- and post-RA incidence. We applied a validated approach to identify HF and extract ejection fraction to classify HFrEF and HFpEF. Follow-up started from the RA incidence date (index date) to the earliest occurrence of incident HF, death, last EHR encounter, or 10 years. Baseline inflammation was assessed using erythrocyte sedimentation rate or C-reactive protein values. Covariates included demographic characteristics, established HF risk factors, and RA-related factors. We tested the association between baseline inflammation with incident HF and its subtypes using Cox proportional hazards models. RESULTS: We studied 9,087 patients with RA; 8.2% developed HF during 10 years of follow-up. Elevated inflammation was associated with increased risk for HF at both 5- and 10-year follow-ups (hazard ratio [HR] 1.66, 95% confidence interval [95% CI] 1.12-2.46 and HR 1.46, 95% CI 1.13-1.90, respectively), which is also seen for HFpEF at 5 years (HR 1.72, 95% CI 1.09-2.70) and 10 years (HR 1.45, 95% CI 1.07-1.94). HFrEF was not associated with inflammation for either follow-up time. CONCLUSION: Elevated inflammation early in RA diagnosis was associated with HF; this association was driven by HFpEF and not HFrEF, suggesting a window of opportunity for prevention of HFpEF in RA.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Huang S, Cai T, Weber BN, et al. Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022. PMID: 34623035. doi:10.1002/acr.24804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。